🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

2023 was a big year for extreme protection against Alzheimer’s: 1) Reelin-Colbos lnkd.in/e45QnVzY, 2) new antibodies drugs lnkd.in/exRjrN4t and 3) validation of the extreme protective effects of ApoE Christchurch

Last year saw a first for the #alzhemers field—traditional FDA approval for a disease-modifying therapy, lecanemab. This energized the field, making 2023 a great year for basic research, too. Read Alzforum’s research highlights from the last 12 months. ow.ly/wIyZ50QrMeB

25 years ago, Joseph Arboleda-Velasquez faced enormous publishing challenges. That's why ScienceBank is here. Here's our story. 👇🏽

We’re excited to announce that Dr. Taruna Ikrar, an eminent Indonesian pharmacologist, will join our Editorial Board. 🎉 Dr. Ikrar is an adjunct professor at Unhan RI and a professor at Universitas Malahayati Bandar Lampung. #pharmacology #cardiology #neuroscience #academia

glad I kept this for so many years…! Never give up on a worthwhile idea! If its worth doing its worth waiting! Equally satisfying was that noise floppy disks make when they are being read… I had not heard it in decades!

We are thrilled to introduce Dr. Manuel F. Navarro-Gonzalez, as a new Editorial board member! 🎊 His international education includes: ✔️ Veterinary Medicine from Caldas University, Colombia ✔️ PhD in Neuroscience from The Australian National University He conducted research

We are delighted to present Dr. Lawrence Kaufman as an Editorial Board member. 🎉 He is a natural leader, founding and leading innovative companies such as: ✔️ Sionex corps  ✔️ Digital Graphics Inc. ✔️ 14 years at Polaroid #leadership #tech #innovation #industryPioneer

frontiersin.org/articles/10.33… More than meets the eye for mechanisms of extreme protection against Alzheimer’s disease by ApoE3 Christchurch! ApoE3Ch functions as an enhancer of Wnt signaling a direct regulator of tau phosphorylation!

A warm welcome to Dr. Leo Kim, our new Editorial Board member! A prominent retina surgeon and professor at Mass. Eye and Ear, Dr. Kim is celebrated for his mastery in treating retinal conditions involving neovascularization and fibrosis, such as: → diabetic retinopathy →

Honored to have Dr. Lucía González-Buendía as part of our Editorial Board! 🥂 Dr. Buendía is a renowned ophthalmologist specializing in the retina and vitreous, focusing on AMD, diabetic retinopathy, and inherited retinal diseases. #opthalmology #education #mentorship #medicine

Dr. Francisco Lopera was awarded the highest honors of the American Neurological Association - the Potamkin Prize! 🥂 The Potamkin Prize honors scientists making groundbreaking discoveries in brain degenerative diseases like Alzheimer's & Pick’s. Warmest congratulations to Dr.

Introducing the esteemed Dr. Jan Manent as our 2024 Editorial Board Deputy! 🌟 Dr. Jan Manent is a researcher and academic coordinator at the Australian Regenerative Medicine Institute in Melbourne where he studies early patterning of the vertebrate embryo. #Science #Research

Call for Papers! 📢 We are excited to announce the launch of our new domain in #Pharmacology under the expert leadership of Dr. Taruna Ikrar, a renowned figure in the field. This domain features a #community #edition led by Dr. Mahmoud Ramadan. 👇 #academia

Having 1 copy of a rare APO allele (Christchurch) provides some protection, 4-5 year delay, from a familial autosomal dominant Alzheimer's disease nejm.org/doi/full/10.10… NEJM Yakeel T. Quiroz, PhD (she/her) Joseph Arboleda-Velasquez despite increased β-amyloid, but less Tau accumulation

On NPR : the protective role of reelin in #Alzheimers with @DrLiHueiTsai and Joseph Arboleda-Velasquez npr.org/2024/07/24/nx-…

So, we were right 😆, @ytquiroz, Joseph Arboleda-Velasquez, Grupo de Neurociencias de Antioquia #Reelin #Alzheimers

El equipo incluye a Dra. Carolina Ospina, Dra. Dorothee Schoemaker, Dra. Lina Marcela Velilla, Dra. Yesica Zuluaga, Dr. Francisco Lopera, Dr. Joseph Arboleda-Velasquez , y Dra. @ytquiroz.

#NewProfilePic

ScienceBank has launched communities! 🥂 With our community-based peer review model, we aim to create a quick and fair peer review process. By organizing worldwide domain #experts into communities dedicated to a specific field, we ensure high-quality #research and #PeerReview.

Some of our communities include: - The NOTCH signaling community led by Joseph Arboleda-Velasquez, PhD - The Biomedical engineering community led by Martha Londoño Lopez, PhD - The Clinical ophthalmology community led by Dr. Lucia Buendia - The Pharmacology community led by Dr. Taruna Ikrar